Catalyst Wire Dossier Catalyst Wire Dossier

cabotegravir + rilpivirine (injectable)

cabotegravir and rilpivirine · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for cabotegravir + rilpivirine (injectable), covering 2022-01-10 to 2022-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) [Phase 3]

See pricing